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Abstract short version 
Introduction: Self monitoring of blood pressure (BP) is an increasingly common part 
of hypertension management. The objectives of this systematic review were to 
evaluate the systolic and diastolic BP reduction, and achievement of target BP, 
associated with self monitoring. 
Methods: Medline and six other databases were searched for studies where the 
intervention included self monitoring of BP and the outcome was change in 
office/ambulatory BP or proportion with controlled BP. Two reviewers independently 
extracted data. Meta analysis using a random effects model was combined with meta-
regression to investigate heterogeneity in effect sizes. 
Results: 25 eligible RCTs were identified. Office systolic (20 RCT’s, 5898 patients)  
and diastolic BP (23 RCTs, 6038 patients) were significantly reduced in those who 
self-monitored compared to usual care (weighted mean difference systolic: -
3.82mmHg (95 % CI -5.61, -2.03) /diastolic -1.45 mmHg (-1.95, -0.94)). Self 
monitoring increased the chance of meeting office BP targets (12 RCTs, 2260 
patients; RR = 1.09 (1.02, 1.16)). There was significant heterogeneity between studies 
for all three comparisons which could be partially accounted for by the use of 
additional co-interventions.  
Conclusion: Self-monitoring reduces blood pressure by a small but significant 
amount. Meta-regression could only account for part of the observed heterogeneity. 
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Abstract long version 
Introduction: Self monitoring of blood pressure (BP) is an increasingly common part 
of hypertension management. The objectives of this systematic review were to 
evaluate the systolic and diastolic BP reduction, and achievement of target BP, 
associated with self monitoring. 
Methods: MEDLINE, Embase, Cochrane database of systematic reviews, database of 
abstracts of clinical effectiveness, the health technology assessment database, the 
NHS economic evaluation database, and the TRIP database were searched for studies 
where the intervention included self monitoring of BP and the outcome was change in 
office/ambulatory BP or proportion with controlled BP. Two reviewers independently 
extracted data. Meta analysis using a random effects model was combined with meta-
regression to investigate heterogeneity in effect sizes. 
Results: 25 eligible RCTs (27 comparisons) were identified. Office systolic (20 
RCT’s, 21 comparisons, 5898 patients) and diastolic BP (23 RCTs, 25 comparisons, 
6038 patients) were significantly reduced in those who self-monitored compared to 
usual care (weighted mean difference (WMD) systolic -3.82mmHg (95 % confidence 
interval -5.61, -2.03) /diastolic -1.45 mmHg (-1.95, -0.94)). Self monitoring increased 
the chance of meeting office BP targets (12 RCTs, 13 comparison, 2260 patients, RR 
= 1.09 (1.02, 1.16)). There was significant heterogeneity between studies for all three 
comparisons which could be partially accounted for by the use of additional co-
interventions.  
Conclusion: Self-monitoring reduces blood pressure by a small but significant 
amount. Meta-regression could only account for part of the observed heterogeneity. 
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Monitoring 
 
Key messages:  
1) Self-monitoring of blood pressure results in small reductions in office blood 
pressure but there is significant heterogeneity of results between studies 
2) Metaregression to investigate this heterogeneity found that additional co-
interventions such as telemonitoring or education explained part but not all of 
the heterogeneity in studies with achievement of blood pressure target as their 
outcome. 
3) Other factors not studied may play an important role in the remaining 
heterogeneity and may be best studied by an individual patient meta-analysis.  
 
Abbreviations 
mmHg; Millimetres of Mercury 
BP; Blood Pressure 
RCT(s); Randomised Controlled Trial(s) 
SBP: systolic Blood Pressure 
DBP: Diastolic Blood Pressure 
WMD; Weighted Mean Difference 
ABPM: Ambulatory Blood Pressure Measurement 
RR: Relative Risk 
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Introduction 
Hypertension is a key risk factor for cardiovascular disease, the leading cause of death 
worldwide.1 Therapeutic reduction of blood pressure leads to significant reduction in 
both stroke and coronary heart disease risk and is cost effective, especially for 
individuals at higher risk of cardiovascular events.2, 3 However, international 
community based surveys indicate that only a minority of people treated for 
hypertension are controlled to recommended treatment levels.4  
 
Self monitoring of hypertension has been proposed as a method for reducing blood 
pressure over and above standard care by increasing the involvement of individuals in 
their own treatment and therefore aiming to increase adherence, reduce clinical inertia 
and provide patients and professionals with common information about the efficacy of 
treatment.5, 6 Self measurement is a better predictor of end organ damage than office 
measurement 7 and is well tolerated by patients.8, 9  
 
Previous systematic reviews have found self monitoring of blood pressure to be 
associated with lower office systolic blood pressure (around 4 mmHg) as compared to 
conventional care but also found large variation in effect size with significant 
heterogeneity between studies.5, 10  No reviews have reported the effect of self 
monitoring using ambulatory blood pressure as the outcome. The heterogeneity 
previously reported may reflect the substantial variation in a number of key variables 
such as the study setting, the methodologies employed (e.g., length of follow-up, 
measurement of BP (how, when and by whom), co-interventions, the BP definitions 
utilised), and the classification criteria for home, self, and usual care. Since these 
previous meta-analyses were performed, a number of new trials have been published. 
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The aim of this study was therefore to provide an updated systematic review of the 
evidence for self monitoring in hypertension and to explore any heterogeneity found 
using meta regression. The objectives were to determine the effect of self monitoring 
of blood pressure in adults on blood pressure and blood pressure control, compared to 
usual care (no self monitoring of BP). The outcomes used were office and ambulatory 
systolic and diastolic blood pressure, and number of patients meeting office target 
blood pressure. [The protocol for this review can be found in appendix 1 (include as 
web appendix)].  
 
Methods 
Searching 
Electronic databases (Medline, Embase, Cochrane database of systematic reviews, 
database of abstracts of clinical effectiveness, the health technology assessment 
database, the NHS economic evaluation database, and the TRIP database) were 
searched in February 2009 for articles published up to and including January 2009, 
using a search strategy (Appendix 2) based on those used in previous meta-analyses 
which was designed to capture all randomised controlled trials (RCTs) concerning 
self monitoring and self management of hypertension.5, 10 Additionally, reference lists 
from included studies and previous meta-analyses were searched. Reference titles and 
abstracts of publications resulting from the search were scrutinised independently by 
two reviewers and potentially eligible studies reviewed in detail to assess eligibility. 
 
Selection 
RCTs were eligible if the intervention tested included self measurement of BP without 
medical professional input, if usual care did not include patient self-monitoring, and if 
 7 
a blood pressure outcome measure was available that had been taken independently of 
the self measurement (either systolic or diastolic office pressure or ambulatory 
monitoring (mean day time ambulatory pressure)). Non randomised designs were 
excluded. No additional quality criteria in terms of methodology or study size were 
applied.11 
 
Data extraction 
Data were extracted independently using a coding form [included as web appendix 3] 
by two reviewers (RM and EB) concerning patient characteristics (gender, age), study 
characteristics (length of follow up), type of self monitoring (home, community), co-
interventions (any procedure over and above self monitoring that was included in the 
intervention including patient education, nurse led support, telemonitoring), and 
outcomes (see below). Where data were missing from published reports, for instance 
standard deviations of change, authors were contacted to request such information. 
Where studies reported more than one outcome time (e.g. 6 and 12 months), data 
concerning the longest follow up was extracted. In cases of disagreement that could 
not be resolved by consensus, a third reviewer (JM) adjudicated.  
 
Outcomes 
The outcomes assessed were change in mean office SBP and DBP, change in mean 
day-time ambulatory SBP and DBP between baseline and follow up for both 
intervention and control arms, and change in proportion of people with office 
measured BP controlled below target between intervention and control arms. Data 
were also collected on whether adjustments were made for self-monitored readings 
compared to office readings.  
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Quantitative data synthesis 
Analyses were performed with STATA 10.1 (Statacorp) using a random-effects 
model (metan command). Weighted mean differences (WMD) were calculated for the 
overall mean change in systolic and diastolic blood pressure (both office and ABPM) 
between intervention and control, with relative risk (RR) used when percentage of 
patients with BP above target at final follow-up was reported. The weighting 
depended on the standard deviation of the change in BP from baseline to final reading 
and this value was not always reported but standard deviations at baseline and final 
measurements were given. Elementary theory of differences of correlated variables 
was used to estimate the standard deviation of change on those occasions. The 
correlation between baseline and final result was estimated from studies where all 
three standard deviations were reported and then used in conjunction with the latter 
two standard deviations to estimate the standard deviation of change when not 
available. Where either of the latter two standard deviations were missing then an 
average value from the other studies was imputed. [The data used and an explanation 
of the standard deviation estimation can be found in web appendix 4]. 
 
Clinical heterogeneity was assessed using a chi-square test for systematic variation 
and I2. Heterogeneity was further explored using meta-regression with backward 
elimination to analyse the associations between treatment effect and the study 
characteristics (metareg command). Where a significant moderator of the 
heterogeneity was found, studies were grouped using this moderator and if 
heterogeneity of effect size persisted with respect to blood pressure change, further 
meta regression was performed within groups. A priori, on the basis of results from 
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previous studies suggesting an effect on outcome, we included terms for age 
(continuous) and sex  of participants,12, 13 length of follow up (continuous),6 use of 
additional co-interventions (where these were part of the intervention in addition to 
self monitoring),10 adjustment made for self-monitored BP readings, and inclusion 
criteria for diastolic blood pressure (DBP of ≥90 v ≥95 mmHg) in the regression 
models.5 Meta-regression was not used for the ambulatory BP outcome, due to the 
small number of studies involved. A series of sensitivity analyses were performed to 
assess the impact of each study on the overall outcome with recalculation of both the 
weighted mean differences and meta regression as each study was removed one at a 
time from the analysis. A specific sensitivity analysis considered whether studies with 
multiple arms influenced the degree of heterogeneity as measured by I2. 
 
Publication bias was assessed by producing funnel plots of effect size and of sample 
size against WMD to provide a visual review of any potential bias. 
 
Results 
The search results are presented in Figure 1. Of 630 studies included in the original 
search results, 25 studies including 27 comparisons were eligible for the meta analysis 
(Table 1). Two studies included three arms and so were included twice.14, 15 Of these, 
20 RCTs (21 comparisons, 5898 patients) contained extractable data on change in 
office systolic blood pressure, 23 RCTs (25 comparisons, 6038 patients) data for 
change in office diastolic blood pressure, 12 RCTs, (13 comparisons, 2260 patients) 
data for achievement of office blood pressure target and three studies for change in 
mean day time ambulatory BP (SBP and DBP) (3 comparisons, 572 patients).  
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Nine studies included follow up of one year or more and the mean age of participants 
ranged from 47 to 77 with 18 studies having a mean age of less than 60 (table 1). Six 
studies included 200 or more patients per randomised group. Thirteen studies included 
no additional intervention other than self monitoring. Additional co-interventions over 
and above self monitoring included patient education (7 studies), phone contact or 
home visits (7 studies), family involvement (1 study) and telemetry (6 studies). Seven 
studies included more than one additional co-intervention. The treating physician was 
aware of self blood pressure readings in 16 studies. 
 
Office Systolic Blood Pressure 
Systolic blood pressure was significantly reduced in those who received self-
monitoring compared to usual care (weighted mean difference = -3.82mmHg, (95 % 
CI -5.61 to -2.03) Figure 2). However, there was a high level of heterogeneity 
between the studies (I2 = 71.9%, p<.001). Subsequent meta-regression demonstrated 
that of the six variables investigated as moderators for this heterogeneity, none 
approached significance (Table 2).  
 
Sensitivity analyses, which examined the influence of each individual study on the 
overall effect size estimate by removing each study in turn from the analysis, revealed 
a range of weighted mean differences of between -3.14 and -4.11 mmHg, with no 
single study affecting the overall heterogeneity. In particular the Green study which 
was included twice did not have any distorting effect. 
 
Office Diastolic Blood pressure 
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Diastolic blood pressure was significantly reduced in those who received self-
monitoring compared to usual care (weighted mean difference  = -1.45mmHg (95 % 
CI -1.95 to -0.94), Figure 3). Again, there was significant (albeit this time moderate) 
heterogeneity between the studies (I2 = 42.1%, p<0.01). Meta-regression 
demonstrated that none of the six variables investigated as moderators approached 
significance (Table 2).  
 
The range of weighted mean differences seen in the sensitivity analysis removing 
each study in turn from the analysis was between -1.23 and -1.62 mmHg. On five 
occasions, removing a single included study had an effect on the resultant meta-
analyses and meta-regressions of the remaining studies: with Haynes16 removed 
gender approached significance as a moderator (p=0.075) and with Binstock,17 Green 
(a),14 Parati18 and Marquez-Contreras19 removed, co-interventions approached 
significance as a moderator (p=0.056, p=0.069, p = 0.05,  p=0.091, respectively). A 
sensitivity analysis of the two trials included twice examining their effect on z scores 
and I2 was consistent with the magnitude of the individual effect sizes and suggested 
no distortion caused by including both arms of these trials. 
 
Office Target Blood Pressure 
Self monitoring of blood pressure (12 RCTs, 13 comparisons) increased the chance of 
meeting target compared to usual care (relative risk = 1.09 (95% CI 1.02 to 1.16), 
Figure 4). There was significant heterogeneity between the studies (I2 = 73.6%, p 
<.01) which was moderated by the presence of a co-intervention (t = 2.39, p<0.05) in 
the meta-regression (Table 2). Where self monitoring was accompanied by an 
additional co-intervention, participants were more likely to meet target BP compared 
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to where there was none (RR = 1.34, (95% CI 1.2 to 1.51), vs RR = 0.98, (95% CI 
0.91 to 1.05)). However, none of the other included moderators could explain the 
heterogeneity which remained in both groups.  
 
Sensitivity analyses showed that removing each study individually made little 
difference to the overall relative risk (range 0.97 to 1.03). None of these analyses 
affected the remaining heterogeneity in the relative risk.   
 
Fewer than half of the studies reported achievement of target blood pressure as an 
outcome. To determine if there was bias related to choice of outcome, the SBP and 
DBP office analyses were re-run including only those studies that also reported target 
BP. These analyses had little impact on the overall effect size (SBP WMD = -
3.2mmHg (95% CI -5.65 to -0.75), DBP WMD = -1.45mmHg (95% CI -2.57 to -
0.47)) suggesting little if any bias in terms of chosen outcome for the target analysis.  
 
Day-time Ambulatory Blood Pressure  
Mean day-time ambulatory blood pressure was reduced but not significantly in those 
who received self-monitoring compared to usual care (three studies, weighted mean 
difference = SBP: -2.04mmHg (95 % CI -4.35 to 0.27), I2 <0.05%, p=0.89 figure 5a, 
and DBP: -0.79mmHg (95% CI -2.35 to .77), I2 <0.05% p=0.96), figure 5b). The I2 
suggested homogeneity but has limited power with only three studies. Sensitivity 
analyses removing each study in turn showed that the Parati study (which included 
telemonitoring)18 had the greatest effect altering the WMD by about 0.5 mmHg in 
both the SBP and DBP analyses. However, none of these analyses altered the non-
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significant nature of the results. An analysis for target ambulatory BP was not 
undertaken as these data were only reported in the Parati study. 
 
Publication Bias 
Funnel plots [see web appendix 5] imply several unpublished negative studies may 
exist but that these are likely to have small (<100) sample sizes and thus little effect 
on the overall results. 
 
Discussion 
This review has found that self monitoring has a small but significant effect on blood 
pressure control: As with previous meta-analyses, significant heterogeneity was 
apparent between all studies with office blood pressure as the outcome.5, 10 Meta-
regression to investigate this heterogeneity was not explanatory for the comparisons 
with office blood pressure as an outcome but sensitivity analyses considering office 
diastolic pressure showed that five studies individually influenced this heterogeneity. 
In four cases absence of these studies resulted in co-interventions becoming a 
significant moderator of this heterogeneity. In the case of the target blood pressure 
analysis, meta-regression showed that studies including additional co-interventions 
were more likely to result in blood pressure control and that this explained some but 
not all of the heterogeneity. Where ambulatory blood pressure was the end point, a 
smaller and non significant reduction in daytime ambulatory blood pressure was 
observed. This may reflect a lack of power with only three studies included.  
 
This meta-analysis, unlike previous work, provides some explanation of the 
heterogeneity observed between studies, particularly in terms of the co-interventions 
 14 
used.5, 10 The range of co-interventions utilised in the included trials was wide and 
included patient education, health professional support (phone calls, pharmacist 
involvement, additional clinic visits or home visits), patient led drug titration, 
techniques designed to increase medication compliance, and use of a website and 
telemonitoring with automated feedback. It is perhaps unsurprising that these could 
enhance the effect of self monitoring given that multi faceted interventions are more 
likely to result in improvements in outcome, and this was seen definitively in the 
target blood pressure analysis.20  
 
Blood pressure drops with repeated measurement,21 and it has been previously 
suggested that habituation to measurement might be the mode of action of self 
monitoring. The smaller effect size seen in the ambulatory monitoring analysis 
provides some support for this argument, but included only three studies hence should 
be interpreted with caution.18, 22, 23 Furthermore, if habituation had a large effect it 
might have been expected that the length of study would have moderated some of the 
heterogeneity in the meta regression, but this was not observed.  
 
The recent scientific statement from the American Heart Association, American 
Society for Hypertension and Preventive Cardiovascular Nurses Association 
recommends that the target self blood pressure goal for treatment is <135/85mmHg or 
<130/80mmHg in high-risk patients.24 The evidence underlying these 
recommendations is not robust: the majority of trials included in this meta-analyses 
report target “office blood pressure” of 140/85-95 mmHg but many do not explicitly 
state whether the same target levels were applied to the self monitoring. The 
importance of this can be seen from the results from the THOP trial where the same 
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target was used for both self and office measurements and it was found that basing 
treatment decisions on self readings led to higher blood pressures than basing them on 
office readings.25  
 
The current paper includes more than double the number of patients in previous meta-
analyses and has resulted in a reduction in the point estimates of effect size for both 
systolic and diastolic blood pressure. The relatively small effect of self monitoring is 
likely to result in a lack of power in most included studies (only one of which had 
enough patients to detect a 3mmHg difference between groups). This fact, along with 
the evidence from the funnel plots, increases the possibility of unpublished negative 
studies such as has been postulated previously.5  
 
Despite a range of potential moderators chosen a priori to explore the heterogeneity 
between studies including age, sex, length of follow up, and inclusion diastolic blood 
pressure, observed heterogeneity remained largely unexplained by this analysis which 
suggests that other factors may play a role. Possibilities which might be further 
investigated include: the timing of self monitored readings (variation of blood 
pressure during the day may impact on patient’s perceptions of their BP), the setting 
of self monitoring (home, at a GP surgery or in the community), and changes in 
treatment during the study. Further work should also explore the types of co-
interventions and how differing combinations of these might optimise the impact on 
reducing BP and helping patients reach target levels. This might best be done in an 
individual patient data meta analysis. 
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Conclusion 
Self monitoring of blood pressure has a small but significant effect on reduction of 
office blood pressure when compared to usual care. Co-interventions explain part of 
the observed heterogeneity between studies which used achievement of target blood 
pressure as an outcome but most remains unaccounted for. Future investigators should 
consider carefully the design of their intervention and the use of outcomes such as 
ambulatory monitoring that are less likely to be affected by habituation to blood 
pressure measurement. 
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Figure 1 Flow chart of search results 
 
630 unique 
studies resulted 
from searches 
98 Abstracts 
considered 
39 Papers 
considered in 
detail 
25 Studies 
included in the 
review 
532 studies not 
relevant on basis 
of titles 
59 studies not 
relevant on basis 
of abstracts 
5 wrong question (inc wrong outcome) 
4 no data 
3 not RCT 
2 control group self monitored 
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NOTE: Weights are from random effects analysis
Overall  (I-squared = 71.9%, p = 0.000)
Artinian (2001)
Bailey (1999)
Soghikan (1992)
Carnaham (1975)
Rudd (2004)
Halme (2005)
Zillich (2005)
Marquez-Contreras (2006)
Broege(2001)
Verberk (2007)
Freidman (1996)
Vetter (2000)
Baque (2005)
Mehos (2000)
McManus (2005)
Green b (2008)
Midanik (1991)
Parati (2009)
Binstock (1988)
Mulhauser (1993)
ID
Green a (2008)
Study
-3.82 (-5.61, -2.03)
-25.60 (-41.78, -9.42)
5.00 (-6.07, 16.07)
-3.30 (-6.77, 0.17)
-7.50 (-14.28, -0.72)
-8.50 (-14.16, -2.84)
-3.10 (-7.93, 1.73)
-4.40 (-10.52, 1.72)
-4.60 (-9.01, -0.19)
-2.00 (-16.33, 12.33)
0.50 (-3.65, 4.65)
-0.90 (-4.98, 3.18)
-0.50 (-3.07, 2.07)
-0.14 (-2.05, 1.77)
-10.10 (-20.61, 0.41)
-2.30 (-5.47, 0.87)
-9.30 (-11.80, -6.80)
-2.60 (-7.26, 2.06)
-0.20 (-3.84, 3.44)
-18.00 (-27.13, -8.87)
-5.00 (-10.45, 0.45)
WMD (95% CI)
-3.40 (-5.91, -0.89)
100.00
1.07
1.98
6.19
3.75
4.47
5.08
4.16
5.42
1.31
5.63
5.68
6.91
7.37
2.14
6.44
6.96
5.22
6.04
2.61
4.62
Weight
6.95
%
  
0-50 -40 -30 -20 -10 10 20 30 40 50
Favours Intervention Favours Control
Figure 2: Overall Office Systolic BP results 
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Overall  (I-squared = 42.1%, p = 0.015)
Mehos (2000)
Johnson (a) (1978)
Zillich (2005)
Vetter (2000)
McManus (2005)
Artinian (2001)
Soghikan (1992)
Stahl (1984)
Haynes (1976)
Study
Parati (2009)
Marquez-Contreras (2006)
Midanik (1991)
Halme (2005)
Green (b) (2008)
Broege (2001)
Carnaham (1975)
Baque (2005)
Friedman (1996)
Johnson (b) (1978)
ID
Bailey (1999)
Green (a) (2008)
Rudd (2004)
Binstock (1988)
Verberk (2007)
Mulhauser (1993)
-1.45 (-1.95, -0.94)
-6.70 (-12.10, -1.30)
-1.00 (-6.28, 4.28)
-3.20 (-7.70, 1.30)
-1.30 (-2.65, 0.05)
-1.10 (-2.78, 0.58)
-12.30 (-24.00, -0.60)
-1.60 (-3.54, 0.34)
0.30 (-2.86, 3.46)
-3.50 (-8.65, 1.65)
0.40 (-1.95, 2.75)
-3.20 (-5.93, -0.47)
0.10 (-2.83, 3.03)
-1.60 (-5.53, 2.33)
-3.60 (-5.28, -1.92)
-1.00 (-8.98, 6.98)
0.00 (-4.24, 4.24)
-1.20 (-2.54, 0.14)
-2.10 (-4.66, 0.46)
-0.80 (-5.55, 3.95)
WMD (95% CI)
2.00 (-4.54, 8.54)
-0.80 (-2.46, 0.86)
-3.10 (-6.64, 0.44)
-10.00 (-15.79, -4.21)
1.80 (-0.47, 4.07)
-3.00 (-6.26, 0.26)
100.00
0.88
0.92
1.27
14.14
9.12
0.19
6.86
2.57
0.97
%
4.66
3.45
2.98
1.66
9.11
0.40
1.43
14.26
3.92
1.14
Weight
0.60
9.28
2.05
0.77
4.98
2.42
  
0-50 -40 -30 -20 -10 10 20 30 40 50
Favours Intervention Favours Control
Figure 3:Overall Office Diastolic BP results 
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Figure 4: Office Target BP results 
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Figure 5a: Daytime Ambulatory SBP results 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5b: Daytime Ambulatory DBP results 
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Table 1 Summary of randomised studies of self monitoring of blood pressure 
Study Setting and 
subjects 
Mean 
Age 
(years) 
Intervention 
subjects 
Control 
Subjects 
Length of 
follow up 
Type & 
frequency of 
BP self 
measurement 
Description of 
the control 
group 
Intervention group 
regimen over and 
above control plus 
self-monitoring  
Adjustment made 
for self-
measurement 
readings 
Was physician 
adjusting 
medication aware 
of self 
measurement 
readings? 
Outcome 
measurement 
Carnahan 
1975 
US 26 
Hospital clinic, 
patients starting 
treatment for 
hypertension, 
with DBP≥90 
 
 
 
55 
 
49 48 2-8 clinic 
visits per 
6 months  
Manual sphyg 
with built in 
stethoscope  
 
Twice daily 
(upper arm) 
Medication 
adjustment by 
fixed titration 
schedule 
based on clinic 
BP values 
done by nurse 
No additional co-
intervention 
None specified No: 
Nurse run clinic 
blind to home BP 
Clinic BP 
(blinded) 
 
Compliance (pill 
count) 
Haynes 
1976 
US 16  
Non compliant 
men recruited via 
workplace 
screening 
programme; DBP 
≥ 90mmHg 
following initial 
treatment 
No age 
quoted 
 
20 18 0 & 6 
months 
Manual 
anaeroid 
Daily 
(upper arm) 
Not specified Patient education 
and tailored to their 
rituals 
None specified Not clear Blinded external 
BP measurement  
Johnson a * 
1978 
Canada 15 
Subjects 
recruited from 
screening in local 
shopping centre, 
DBP ≥95 mmHg 
despite treatment 
54  
 
36 
 
36 
 
0, 2wks, 
& 6 
months 
Manual sphyg 
 
Daily 
(upper arm) 
Neither home 
visits or self-
recording 
No additional co-
intervention 
 
None specified Yes External blinded 
measurement of 
BP and 
compliance (pill 
count & 
interview) 
Johnson b* 
1978 
Canada15 
Subjects 
recruited from 
screening in local 
shopping centre, 
DBP ≥95 mmHg 
despite treatment 
54 35 36 0, 2wks, 
& 6 
months 
Manual sphyg 
 
Daily 
(upper arm) 
Neither home 
visits or self-
recording 
Home visits every 4 
weeks 
None specified Yes External blinded 
measurement of 
BP and 
compliance (pill 
count & 
interview) 
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Study Setting and 
subjects 
Mean 
Age 
(years) 
Intervention 
subjects 
Control 
Subjects 
Length of 
follow up 
Type & 
frequency of 
BP self 
measurement 
Description of 
the control 
group 
Intervention group 
regimen over and 
above control plus 
self-monitoring  
Adjustment made 
for self-
measurement 
readings 
Was physician 
adjusting 
medication aware 
of self 
measurement 
readings? 
Outcome 
measurement 
Earp  
1982  
US 27 
 Treated 
hypertensives 
with a medication 
change in 
previous 2 mths 
recruited from 
hospital and 
community 
clinics 
48 99 63 24 
months; 
5-6 visits 
Sphygmomano
meter type 
unclear 
Routine 
medical care 
Home visit and 
significant others 
involved 
None specified Not clear DBP control 
Stahl  
1984  
US 28 
Hospital clinic. 
Raised DBP 
under care of 
nurse practitioner 
47.5 144 173 36 
months, 
variable 
number of 
visits 
Mercury Sphyg Not specified No additional co-
intervention 
None specified yes Unblinded 
physician 
measured 
Binstock  
1988  
US 17 
Treated 
hypertensives 
Not 
stated 
23 32 0 & 12 
months 
Not stated. 
Readings done 
at home 
Education 
programme 
educational 
programme plus 
self-monitoring 
None specified Not stated Change in SBP 
and DBP 
Midanik  
1991  
US 29 
Untreated with 
BL DBP 90-
95mmHg and 
SBP< 180mmHg 
47 102 102 0 & 12 
months 
Digital device. 
2 consecutive 
readings, twice 
a week 
Usual care No additional co-
intervention 
None specified Yes Change in SBP 
and DBP 
Soghikhan 
1992 
US 12    
Health 
Maintenance 
Organisation 
Centres. 
Hypertension 
patients 
 
54  215 215 0 & 12 
months 
Electronic 
sphyg 
 
Twice weekly 
Usual care No additional co-
intervention 
None specified Yes Study BP by 
trained 
technicians 
(blinded) 
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Study Setting and 
subjects 
Mean 
Age 
(years) 
Intervention 
subjects 
Control 
Subjects 
Length of 
follow up 
Type & 
frequency of 
BP self 
measurement 
Description of 
the control 
group 
Intervention group 
regimen over and 
above control plus 
self-monitoring  
Adjustment made 
for self-
measurement 
readings 
Was physician 
adjusting 
medication aware 
of self 
measurement 
readings? 
Outcome 
measurement 
Muhlhauser # 
1993  
Germany 30 
Primary Care. 
BP> 160 and/or 
95mmHg 
51 86 74 0 & 18 
months 
Twice daily 
until 
satisfactory 
values 
achieved then 
less frequently 
Normal  care Patient education None specified Yes Hypertensive 
prescription, 
Physician visits 
Friedman  
1996 
US 31 
Community 
physicians’ 
clinics. Treated 
hypertensives 
with SBP ≥ 
160mmHg and/or 
DBP ≥ 
90mmHg 
 
77 
 
133 134 0 & 6 
months 
Automated 
Weekly 
(?upper arm) 
Usual care Patient education 
and telemetry 
None specified “TLC” data 
transmitted to 
patient’s own 
physician 
BP measured on 
home visit; 
protocol for 
measurement not 
clear if blinded 
Bailey 
1999 
Australia 32  
Primary care. 
Hypertensive 
patients not 
practising self-
measurement, 
with or without 
current treatment  
 
 
 
55  
 
31 29 0 & 8 
weeks 
Electronic 
Twice daily 
(upper arm) 
ACE inhibitor 
or diuretic 
No additional co-
intervention 
None specified Yes Externally 
measured BP 
(study nurse). 
Probably not 
blinded 
Vetter 
2000 
Switzerland 33  
Primary care. 
Newly 
diagnosied or 
known 
hypertensives 
with BP 160/200/ 
95-215mmHg  
 
58  
 
296 326 0, 2 & 8 
weeks 
Automated 
(wrist) 
Twice daily 
Losartan 15mg No additional co-
intervention 
None specified Not applicable 
(patients were only 
reviewed at the 
beginning and end 
of the 8 week study 
period) 
Unblinded own 
physician 
measurement 
(mercury sphyg) 
Control of BP (% 
≤ 90mmHg DBP) 
Change in BP 
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Study Setting and 
subjects 
Mean 
Age 
(years) 
Intervention 
subjects 
Control 
Subjects 
Length of 
follow up 
Type & 
frequency of 
BP self 
measurement 
Description of 
the control 
group 
Intervention group 
regimen over and 
above control plus 
self-monitoring  
Adjustment made 
for self-
measurement 
readings 
Was physician 
adjusting 
medication aware 
of self 
measurement 
readings? 
Outcome 
measurement 
Mehos 
2000 
US 34 
Primary care 
patients with 
treated 
hypertension and 
BP between 140-
179/90-
109mmHg 
59  18 18 0 & 6 
months 
Manual 
electronic 
Daily 
Upper arm 
Routine care 
with no 
restrictions on 
number of 
office visits.  
Phone call from 
pharmacist 
None specified Yes Clinic 
measurements 
before and after;  
not clear if  
blinded 
Artinian  
2001  
US 35 
Family 
Community 
Centre. African-
American men 
and women with 
BP≥ 
140 and/or 90 
(diabetic range ≥ 
130/85) 
59 6 9 0 & 3 
months 
Electronic, at 
home, 
minimum 3 
times/week 
Usual care; 
visits to 
primary care 
provider at 
intervals 
requested by 
the primary 
care provider.  
Telemetry, patient 
education and 
nurse visit 
None specified Yes Community 
centre pre and 
post by 
researcher who 
was blinded 
Broege  
2001  
US 22 
Hypertension 
centre or 
community 
health centre. 
Hypertensive 
patients with BP< 
150/90 if on 
treatment or 
>150/90 off 
treatment 
73 20 20 0, 1, 2 & 
3 months 
Semi-
automatic, 3 
times morning 
and evening 
Usual clinic 
treatment 
Monthly clinic visit 
and nurse phone 
call 
No adjustment Yes Clinic and 
Ambulatory SBP 
and DBP 
readings 
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Study Setting and 
subjects 
Mean 
Age 
(years) 
Intervention 
subjects 
Control 
Subjects 
Length of 
follow up 
Type & 
frequency of 
BP self 
measurement 
Description of 
the control 
group 
Intervention group 
regimen over and 
above control plus 
self-monitoring  
Adjustment made 
for self-
measurement 
readings 
Was physician 
adjusting 
medication aware 
of self 
measurement 
readings? 
Outcome 
measurement 
Rudd  
2004  
US 36 
Primary Care 
clinics. 
Hypertensive 
patients with BP 
≥ 
140/90 or on 
anti-
hypertensives, 
eligible for 
treatment under 
JNC VI criteria 
59.5 74 76 0, 3, & 6 
months 
Automated, 
twice daily, at 
home 
Routine care 
as received 
before study 
Patient education 
and nurse phone 
call 
Adjustment of 
10/5mmHg 
Yes Blinded readings 
at 3 and 6 
months. Drug 
monitoring using 
electronic pill 
count bottles 
Baque # 
2005  
Spain 37 
Primary Care 
centres. 
Hypertensive 
patients with BP 
≥ 
140/90mmHg 
61 622 703 0, 6, 8, 
14, 16 & 
24 wks  
Automated,  
15 days at 
weeks 6-8, and 
14-16. 3 
measurements 
in morning 
prior to 
medication, 2 
in evening 
prior to supper.  
None specified No additional co-
intervention 
None specified Encouraged to 
share with 
physician.  
Control of BP  
(SBP 
<140mmHg,  
DBP <90mmHg) 
Halme  
2005  
Finland 38 
Primary Health 
Care. Patients 
with essential 
hypertension, 
taking anyti-
hypertensive 
treatment or BP 
≥ 
140/90 
57 113 119 0 & 6 
months 
Automatic 
home 
readings. 1 
week every 2 
months, twice 
daily 
Usual care; at 
regular local 
practice 
No additional co-
intervention 
Adjustment of 
5/5mmHg 
Yes Office BP taken 
with the home 
monitor. Change 
in SBP and DBP.  
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Study Setting and 
subjects 
Mean 
Age 
(years) 
Intervention 
subjects 
Control 
Subjects 
Length 
of follow 
up 
Type & 
frequency of BP 
self 
measurement 
Description of 
the control 
group 
Intervention group 
regimen over and 
above control plus 
self-monitoring  
Adjustment made 
for self-
measurement 
readings 
Was physician 
adjusting 
medication aware 
of self 
measurement 
readings? 
Outcome 
measurement 
McManus 
2005 
UK 6 
Primary Care. 
Treated 
hypertensives 
with BP 140-
200/85-
100mmHg 
62  214 227 0, 6, & 
12 
months 
Electronic Upper 
Arm monthly in 
practice waiting 
room 
Usual care No additional co-
intervention 
No adjustment Patients 
encouraged to 
share readings 
(approx 50% did) 
Independently 
measured BP at 
0,6 and 12 
months 
Zillich # 
2005  
US 39 
Community 
pharmacies. 
Treated 
hypertensives 
with BP 145-
179/95-109 
(diabetic = 
135-179/90-
109mmHg) 
65 64 61 0, 4, & 
12 wks  
Automatic. 2 
readings 
separated with 5 
min rest, once 
daily in the 
morning 
3 pharmacy 
visits over 
3mths where 
BP measured 
nad referred to 
physician if 
>140/90mmHg 
Patient education. 
Additional visit to 
implement 
treatment 
developed based 
on self readings.  
No adjustment Yes Change in SBP 
and DBP 
Marquez-
Contreras  
2006  
Spain 19 
Primary care 
centres. Mild-
moderate 
hypertension, 
requiring 
treatment (not 
all on 
treatment at 
BL) 
59 100 100 0, 1, 3, 
& 6 
months 
Automatic. 3 
days a week, 
twice before 
breakfast and 
twice before 
supper 
Usual 
treatment from 
GP 
No additional co-
intervention 
None specified No, readings given 
to investigator who 
altered 
medications.  
Mean decrease 
in SBP and DBP 
Verberk  
2007  
Netherlands 13 
Setting, not 
clear. Office 
BP>139 
and/or 
89mmHg 
55 214 216 0 & 12 
months 
Automated. 6 
times a day for 7 
days 
Step-wise anti-
hypertensive 
treatment 
based on office 
readings. 
No additional co-
intervention 
No adjustment Yes Blinded. BP 
control and 
reduction 
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Study Setting and 
subjects 
Mean 
Age 
(years) 
Intervention 
subjects 
Control 
Subjects 
Length 
of follow 
up 
Type & 
frequency of BP 
self 
measurement 
Description of 
the control 
group 
Intervention group 
regimen over and 
above control plus 
self-monitoring  
Adjustment made 
for self-
measurement 
readings 
Was physician 
adjusting 
medication aware 
of self 
measurement 
readings? 
Outcome 
measurement 
Green* a  
2008  
USA 14 
Medical 
Centres. 
Uncontrolled 
treatment 
hypertension 
59 259 258  0 & 12 
months 
Automated. At 
least two days 
per week, twice 
per occasion 
Usual care Received 
hypertension 
pamphlet and 
patient web-site 
pamphlet Use of 
website plus patient 
education 
Adjustment of 
5/5mmHg 
Yes Blinded. BP 
control and 
changes in SBP 
and DBP 
Green * b  
2008  
USA 14 
Medical 
centres. 
Uncontrolled 
treatment 
hypertension 
59 261 258 0 & 12 
months 
Automated. At 
least two days 
per week, twice 
per occasion 
Usual care Received 
hypertension 
pamphlet and 
patient web-site 
pamphlet Use of 
website and 
pharmacist plus 
patient education 
Adjustment of 
5/5mmHg 
Yes Blinded. BP 
control and 
changes in SBP 
and DBP 
Madsen  
2008  
Denmark 23 
General 
practices. 
Newlty 
diagnosed or 
treated but not 
controlled, 
office BP 
>150/95mmHg 
56 113 123 0 & 6 
months 
Semi-automatic. 
3x/wk in 1st 3 
months, then 
once a wk during 
last 3 months. 3 
readings each 
time. 
Usual care telemonitoring Adjustment of 
5/5mmHg 
yes Mean decrease 
in systolic and 
diastolic daytime 
ABPM. 
Parati  
2009  
Italy 18 
Uncontrolled 
essential 
hypertension, 
BP ≥ 140/90, 
plus ABPM ≥ 
130/80 with or 
without 
treatment 
57.5 187 111 0, 4, 12 
& 24 
wks  
Variable Office based 
BP 
management 
Nurse phone call 
and telemetry 
Adjustment of 
5/5mmHg 
yes Change in SBP 
and DBP 
*study had three groups so included twice, once for each comparison  Sphyg = sphygmomanometer  # studies were cluster randomised by practice 
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Table 2: Results from the main meta-regression analyses. 
 
Systolic Office Meta-regression 
 
 Overall backward elimination model Single moderator 
model 
Moderator Coeff p 95% CI p 
Follow-up -0.17 0.57 -0.77 to .44 0.42 
Age 0.39     0.31     -0.40 to 1.18 0.80 
Male 0.09    0.43     -0.14 to .31 0.66 
DBP 0.50    0.88     -6.55 to 7.56 0.93 
Co-
Interventions 
-4.10    0.25     -11.47 to 3.26 0.28 
Adjusted BP -2.16   0.56     -9.89 to 5.56 0.48 
constant -24.65    0.28     -72.06 to 22.75  
 
Diastolic Office Meta-regression 
 
 Overall backward elimination model Single moderator 
model 
Moderator Coeff p 95% CI p 
Follow-up 0.04 0.68 -0.16 to 0.24 0.55 
Age 0.02 0.90 -0.26 to 0.30 0.22 
Male 0.04 0.31 -0.04 to 0.12 0.22 
DBP -0.41 0.75 -3.04 to 2.24 0.59 
Co-
Interventions 
-1.67 0.24 -4.52 to 1.19 0.13 
Adjusted BP -0.96 0.52 -3.99 to 2.10 0.83 
constant -2.57 0.77 -20.06 to 15.09  
 
Target Office Meta-regression 
 
 Overall backward elimination model Single moderator 
model 
Moderator Coeff p 95% CI p 
Follow-up -0.0002 0.99    -0.06 to 0.06 0.65 
Age 0.008  0.83 -0.08 to 0.10 0.43 
Male -0.005    0.72      -0.04 to 0.03 0.60 
DBP -0.087   0.81     -0.94 to 0.76 0.92 
Co-
Interventions 
0.41    0.14     -0.17 to 0.99 0.04 
Adjusted BP 0.19   0.54     -0.52 to 0.90 0.33 
constant -0.60    0.84     -7.31 to 6.12  
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